Inert coupling of IRDye800CW and zirconium-89 to monoclonal antibodies for single- or dual-mode fluorescence and PET imaging

Nature Protocols

Volumn 8, Issue 5, 2013, Pages 1010-1018

  Cohen, Ruth ^a   Vugts, Danielle J ^a   Stigter Van Walsum, Marijke ^a   Visser, Gerard W M ^a   Van Dongen, Guus A M S ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; IRDYE800CW N SUCCINYLDESFERRIOXAMINE MONOCLONAL ANTIBODY ZIRCONIUM 89 CONJUGATE; N SUCCINYLDEFEROXAMINE; UNCLASSIFIED DRUG; ZIRCONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); DOSIMETRY; FLUORESCENCE IMAGING; GEL FILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMAGE ANALYSIS; ISOTOPE LABELING; MOLECULAR IMAGING; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PURIFICATION; RADIATION DOSE DISTRIBUTION; RADIATION EXPOSURE; SEQUENCE ANALYSIS; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; BENZENESULFONATES; INDOLES; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; POSITRON-EMISSION TOMOGRAPHY; STAINING AND LABELING; ZIRCONIUM;

EID: 84877039050     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2013.054     Document Type: Article

References (24)

1. Van Dongen, G.A.M.S. et al. Immuno-PET: A navigator in monoclonal antibody development and applications. Oncologist 12, 1379-1389 (2007
2. Van Dongen, G.A.M.S. & Vosjan, M.J.D.W. Immuno-PET: Shedding light on clinical antibody development. Cancer Biother. Radiopharm. 25, 375-385 (2010
3. Weissleder, R. Molecular imaging: Exploring the next frontier. Radiology 212, 609-614 (1999
4. Te Velde, E.A. et al. The use of fluorescent dyes and probes in surgical oncology. Eur. J. Surg. Oncol. 36, 6-15 (2010
5. Frangioni, J.V. In vivo near-infrared fluorescence imaging. Curr. Opin. Chem. Biol. 7, 626-634 (2003
6. Van Dam, G.M. et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: First in-human results. Nat. Med. 17, 1315-1319 (2011
7. Ito, S., Muguruma, N. & Hayashi, S. et al. Development of agents for reinforcement of fluorescence on near-infrared ray excitation for immunohistological staining. Bioorg. Med. Chem. 6, 613-618 (1998
8. Kovar, J.L. et al. A systemic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models. Anal. Biochem. 367, 1-12 (2007
9. Terwisscha van Scheltinga, A.G. et al. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies. J. Nucl. Med. 52, 1778-1785 (2011
10. Oliveira, S. et al. Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobody. Mol. Imaging 11, 33-46 (2012
11. Marchall, M.V. et al. Single-dose intravenous toxicology study of IRDye800CW in Spraque-Dawley rats. Mol. Imaging Biol. 12, 583-594 (2010
12. Verel, I. et al. 89Zr immuno-PET: Comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies. J. Nucl. Med. 44, 1271-1281 (2003
13. Vosjan, M.J.W.D. et al. Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine. Nat. Protoc. 5, 739-743 (2010
14. Vugts, D.J., Visser, G.W.M. & Van Dongen, G.A.M.S. 89Zr-PET in the development and application of therapeutic monoclonal antibodies and other biologicals. Curr. Top. Med. Chem. (in the press) (2013
15. Borjesson, P.K. et al. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients. Clin. Cancer Res. 12, 2133-2140 (2006
16. Dijkers, E.C. et al. Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer. Clin. Pharmacol. Ther. 87, 586-592 (2010
17. Williams, S-P. Tissue distribution studies of protein therapeutics using molecular probes: Molecular imaging. AAPS J. 14, 389-399 (2012
18. Oliviera, S. et al. A novel method to quantify IRDye800CW-fluorescent antibody probes ex vivo in tissue distribution studies. EJNMMI Res. 2, 50 (2012
19. Van Gog, F.B. et al. Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: Relationship between the number of chelated groups and biodistribution characteristics. J. Nucl. Med. 37, 352-362 (1996
20. Pèlegrin, A. et al. Antibody-fluorescein conjugates for photoimmunodiagnosis of human colon carcinoma in nude mice. Cancer 67, 2529-2537 (1991
21. Wu, F., Tamhane, M. & Morris, M.E. Pharmacokinetics, lymph node uptake, and mechanistic PK model of near-infrared dye-labeled bevacizumab after IV and SC administration in mice. AAPS J. 14, 252-261 (2012
22. Sampath, L. et al. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J. Nucl. Med. 48, 1501-1510.
23. Sampath, L. et al. Detection of cancer metastases with a dual-labeled near-infrared/positron emission tomography imaging agent. Transl. Oncol. 3, 307-317 (2010
24. Cohen, R. Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets. EJNMMI Res. 1, 31 (2011)